Sarah Ackley
Postdoctoral Associate (previously held)
Boston University School of Public Health
Epidemiology




Sarah Ackley is a dementia epidemiologist in the Department of Epidemiology at the Boston University School of Public Health. Her research agenda has been shaped by contemporary controversies in clinical Alzheimer’s research surrounding the amyloid hypothesis and emerging pharmaceutical treatments. Sarah’s work to date has focused on synthesizing available evidence using rigorous tools to determine drug efficacy; on determining whether amyloid removal provides cognitive benefit; and on biomarker validation in more representative populations. Sarah’s future research will continue to bridge mathematical modeling, neuroimaging, causal inference, and computer simulation to improve evaluations of dementia drugs and better characterize pathology.


Mathematical Models of Tau-PET Measures and Cognitive Decline in Alzheimer's Disease Across the Lifespan
08/01/2023 - 06/30/2024 (PI)
NIH/National Institute on Aging
7K99AG073454-03



Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.


This graph shows the total number of publications by year, by first, middle/unknown, or last author.




Can Diabetes Drugs Lower the Risk of Age-Related Dementia?

WebMD 11/6/2023

Have Diabetes? Quitting Metformin Could Take Toll on Your Brain

US News & World Report 10/26/2023

Stopping diabetes drug metformin early may raise risk for dementia

UPI 10/26/2023
Contact for Mentoring:

Media Mentions
_
Same Department
Search Department